Bard PowerPort Catheter Marketing & Claimant Acquisition

The litigation landscape

Litigation against Bard Medical and BD focuses on allegations that the polyurethane construction of the PowerPort catheter is prone to fracture during or after implantation, allowing device fragments to migrate through the vascular system. The injuries at the center of these claims — catheter fracture, migration, and cardiac injury — are serious, documentable through imaging and surgical records, and in the strongest cases required surgical intervention to address. That combination of a named, widely distributed implant and a discrete, medically confirmed failure mode creates a litigation landscape well-suited to structured claimant acquisition.

Because the PowerPort is an implanted device with a known manufacturer and a specific model identity, plaintiff firms can build dockets around claimants whose medical records will either confirm or rule out the core allegations relatively early in intake. That efficiency matters when evaluating the economics of a paid acquisition campaign — and it shapes how MTAA structures targeting, creative, and the qualification funnel for this tort.

Who a campaign targets

• Primary target audience: Individuals who had a Bard PowerPort implanted and subsequently experienced a confirmed catheter fracture or device migration — particularly those whose condition required surgical intervention to correct.
• Strongest claimant profile: Documented PowerPort implant + imaging or surgical evidence of fracture or migration + procedure required to retrieve or address the migrated fragment or damaged catheter.
• Secondary / borderline profile: Individuals who experienced a device malfunction — port failure, flow issues, or other anomalies — but whose records do not yet confirm fracture or migration. These cases warrant intake review but carry more uncertainty and should be weighted accordingly in campaign economics.
• Intake framing for the firm: Campaigns should be structured to drive highest volume among the fracture/migration/surgical-intervention profile, with a secondary intake path that captures borderline claimants for attorney review rather than automatic qualification.

How MTAA runs Bard PowerPort Catheter campaigns

The creative strategy for a Bard PowerPort campaign leans on the implant's name recognition and the visceral specificity of the injury. Patients who experienced a catheter fracture or were told a fragment had migrated toward their heart remember that moment — the diagnosis, the follow-up imaging, the conversation about surgery. Facebook and Instagram creative that speaks directly to that experience, using plain language about port catheters breaking or moving inside the body, will resonate with the right audience and self-select against unrelated device claims. MTAA builds ad sets around this specificity: the device name, the failure type, and the medical intervention — not generic 'medical device lawsuit' language that attracts noise.

On the audience side, Meta's health-adjacent interest and behavioral signals, combined with geographic and demographic layering consistent with the population that receives implanted port catheters — often oncology and chronic-illness patients who required long-term IV access — allow us to concentrate spend where it converts. Intake flow for this tort benefits from a short, structured pre-qualification sequence that confirms implant identity and injury type before a lead reaches your intake team, keeping cost-per-qualified-claimant in check and reducing time spent on borderline or unrelated submissions.